学院教职员

教学人员
回到主页
​Prof. Dong DONG 董咚教授

董咚教授

Prof. Dong DONG

BA (Fudan), MPhil (CUHK), PhD (U of Minnesota, Twin Cities)

助理教授

电邮: dongdong@cuhk.edu.hk

 

ORCID: 0000-0001-9784-6472

​

个人简介

董教授于2018年加入了公共卫生与基层医疗学院并任职研究助理教授。她曾在明尼苏达大学双城分校获得了大众传播学博士学位（副修流行病学）。董博士的大部分研究都是跨学科的，她不仅关注健康传播和社会医学的相关问题，还着眼于健康公平和社会公正。她曾担任多项校外研究基金项目的首席研究员，其中包括产前基因检测技术在中国大陆的应用，该项目获香港研究资助局优配研究金资助。同时，她也是香港和中国大陆多个研究基金项目的合作研究者，项目研究内容涉及社区健康、健康不平等及医疗服务等问题。

 

此外，董教授正与中国多个全国性的患者组织合作，来调查、追踪和记录受不同类型罕见病影响的中国人的医疗、社会和经济状况。她目前正在领导一个位于中大深圳研究院的研究实验室，着力于开发一个以患者为中心的真实世界数据库，以用于研究中国的罕见病患者。目前董教授已经发表了十几篇有关该课题的白皮书报告，同时她还担任三个全国性罕见病患者组织的董事会成员。

​研究方向

  • 罕见病

  • 健康传播学

  • 医学社会学

  • 健康公平和社会正义

  • 生殖遗传学的科学和技术研究。

  • 跨文化研究

  • 定性研究方法

  • 混合方法研究设计

近期获资助研究项目

  • As Principle Investigator

    • ​2020-2021 Real-world research of people with rare diseases in China. Funded by Beijing Society of Rare Disease Clinical Care and Accessibility. RMB500,000

    • 2020-2021 Hong Kong parents’ perceptions on Down syndrome: A Q-method study. Direct Grant, CUHK. HK$61,000

    • 2020-2021 An international field study for the reliability and validity of the Phase IV EORTC Quality of Life modules for patients with Hodgkin’s Lymphoma (EORTC QLQ-HL27), high-grade non-Hodgkin’s Lymphoma (EORTC QLQ-NHL-HG29), low-grade non-Hodgkin’s Lymphoma (EORTC QLQ-NHL-LG20), and Chronic Lymphocytic Leukaemia (EORTC QLQ-CLL17). The European Organisation for Research and Treatment of Cancer (EORTC, AISBL-IVSW). €5,375.

    • 2019-2021 GHMUA Great Bay Symposium on Rare Diseases. Funded by “Funding for Sub Alliance-粵港澳高校公共衛生聯盟，”OALC, CUHK. HK$50,000.

    • 2019-2021 The general social survey of people affected by rare diseases in China: A baseline study. Funded by Beijing RYBH Foundation. RMB 254,200

    • 2017-2020 Winning the “Second Chance”: Prenatal genetic testing, personal choices and national future. RGC General Research Fund (GRF). HK$789,888

​​

  • As Co-Principle Investigator

    • 2016-2020 Centre for Research into Circulating Fetal Nucleic Acids. Theme-based Research Scheme Project. HK$31.28M

 

  • As Co-Investigator

    • 2020-2022 Investigation of Hong Kong’s early detection, assessment and response (S-EDAR) system to the new emerging infectious disease outbreak COVID-19. Food and Health Bureau - Health and Medical Research Fund Commissioned Research on the Novel Coronavirus Disease (COVID-19). HK$2,970,000

    • 2020-2022 Healthcare Professionals’ Perceptions on Post Discharge Information Summary (PDIS): application of the Theoretical Domains Framework (TDF) to identify barriers and enablers for implementation. Food and Health Bureau - Health and Medical Research Fund, HK$930,032

    • 2019-2022 Tender for the Provision of Services of the Monitoring and Evaluation Study of Kwai Tsing District Health Centre. Food and Health Bureau, $25,251,930

    • 2017- 2020 Uneven distribution of high-quality healthcare resources in Chinese cities and its sociospatial implications. National Natural Science Foundation of China (NSFC), RMB 1,020,800

部份学术文章

Rare diseases:

  1. Xu RH, Wong ELY, Jin J, Dou Y, Dong D.* (2020). Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas. The European Journal of Health Economics (SSCI, Q1, *corresponding author)

  2. Dong, D., Jin, J., Oerlemans, S. et al. (2020) Validation of the Chinese EORTC chronic lymphocytic leukemia module – application of classical test theory and item response theory. Health and Quality of Life Outcomes 18, 96 (2020). https://doi.org/10.1186/s12955-020-01341-z (SSCI & SCIE, Q2)

  3. Yan, X.; He, S.; Dong, D*. (2020). Determining How Far an Adult Rare Disease Patient Needs to Travel for a Definitive Diagnosis: A Cross-Sectional Examination of the 2018 National Rare Disease Survey in China. International Journal of Environmental Research and Public Health 2020, 17, 1757. (*Corresponding author, SSCI Q1)

  4. Yan X., Dong D., He SJ, and Webster CJ. (2020). Examining trans-provincial diagnosis of rare diseases in China: The importance of healthcare resource distribution and patient mobility. Sustainability. (SSCI, Q2)

  5. Dong D.* & Wang Y. (2016). Challenges of rare diseases in China. The Lancet, 387(10031), 1906. doi: 10.1016/s0140-6736(16)30418-4. (SCIE, Q1, *corresponding author, Correspondence)

​

Health equity and social justice

  1. Chen, S., Chen, Y., Feng, Z. et al. Dong D*. (2020). Barriers of effective health insurance coverage for rural-to-urban migrant workers in China: a systematic review and policy gap analysis. BMC Public Health 20, 408 (2020). doi: 10.1186/s12889-020-8448-8 (*correspondence author, SCIE Q2)

  2. Chung, RYN, Dong D., Chan, NNZ, Chau, PYK, Yeoh EK, and Wong ELY. (2020). Examining the Gaps and Issues of End-of-Life Care among Older Population through the Lens of Socioecological Model – A Multi-Method Study of Hong Kong, World’s Leader in Life Expectancy. International Journal of Environmental Research and Public Health (SSCI, Q1)

  3. Chung, G.K., Dong, D., Wong, S.Y. et al. (2020). Perceived poverty and health, and their roles in the poverty-health vicious cycle: a qualitative study of major stakeholders in the healthcare setting in Hong Kong. International Journal for Equity in Health 19, 13 (2020). https://doi.org/10.1186/s12939-020-1127-7 (SSCI, Q1)

  4. Griffiths SM, Dong D., Chung RYN. (2018). Forgotten needs of children left behind by migration. The Lancet, Volume 392, Issue 10164, pg. 2518-2519, doi.org/10.1016/S0140-6736(18)33004-6. (SCIE, invited commentary)

  5. Tang, SF, Dong D, Lu J, et al. (2015). What contributes to the activeness of ethnic minority patients with chronic illnesses seeking allied health services? A cross-sectional study in rural western China. International Journal of Environmental Research and Public Health, 12 (9), 11579-11593. doi:10.3390/ijerph120911579. (SSCI, Q1)


Reprogenetics and informed decision-making

  1. Zhu JF & Dong D. (2018). From quality control to informed choice: Understanding “good birth” and prenatal genetic testing in contemporary urban China. In Routledge Handbook for Genomics, Health and Society (pp.47-54). London: Routledge, 2018.

  2. Ahmed S., Jafri H, Rashid Y, Yi H, Dong D., Zhu JF, and Ahmed M. (2019). Autonomous decision-making for antenatal screening in Pakistan: views held by women, men and health professionals in a low-middle income country. European Journal of Human Genetics (SCIE, Q2)

  3. Ahmed S., Yi H, Dong D., Zhu JF, Jafri H., Rashid Y, Ngan OMY, and Ahmed M. (2018). Interpretations of autonomous decision-making in antenatal genetic screening among women in China, Hong Kong and Pakistan. European Journal of Human Genetics, 4(26), 495-504. doi:10.1038/s41431-017-0091-1. (SCIE, Q2)


Health communication

  1. Fu H., Dong D.*, Feng D. et al. (2017). To share or not to share: A cross-sectional study on health information sharing and its determinants among Chinese rural chronic patients. Journal of Health Communication, 22(10), 800-807. (SSCI, Q1, *co-first author)

  2. Dong, D.* & Chan K. (2016). Authorization, rationalization, and moral evaluation: Legitimizing acupuncture in Hong Kong’s newspapers. Asian Journal of Communication, 26 (2), pp.114-132. doi: 10.1080/01292986.2015.1089915 (SSCI, *corresponding author).

  3. Dong D., Chang TK & Chen D. (2008). Reporting AIDS and the invisible victims in China: Official knowledge as news in the People’s Daily, 1986-2002. Journal of Health Communication, 12 (4), 357-374. (SSCI, Q1)


Edited book:

  1. Chan K. & Dong D. (eds.) Traditional Chinese Medicine: Professionalization and Integration in Hong Kong. City University of Hong Kong Press, 2019

Last Updated: 27 July 2020